Antares Pharma, Inc. (ATRS)

R&D Expenses

$5.01M

Quarterly · Period ending: · USD

ATRS logo

ATRS R&D Expenses

Latest reported$5.01M
ATRS Quarterly R&D Expenses ($0.00 → $5.01M)
High-resolution chart · PNG

ATRS r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
600,000
784,806
600,000
600,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.